Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food, and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride, and Xprecia Prime, which are medical devices; Sentia non-medical wine testing products, and Petrackr, which is a blood glucose test used in cats and dogs. It has one reportable segment: a specialist biosensors company. Geographically, the company generates the majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
76
Stocks News & Analysis
stocks
Finding yield on the ASX
stocks
ExxonMobil earnings: Continued execution, on track for 2030 targets
stocks
Disney earnings: No big surprises in solid results
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,160.90 | 4.70 | 0.05% |
| CAC 40 | 8,181.17 | 54.64 | 0.67% |
| DAX 40 | 24,797.52 | 258.71 | 1.05% |
| Dow JONES (US) | 49,407.66 | 515.19 | 1.05% |
| FTSE 100 | 10,341.56 | 118.02 | 1.15% |
| HKSE | 26,745.75 | 29.82 | -0.11% |
| NASDAQ | 23,592.11 | 130.29 | 0.56% |
| Nikkei 225 | 54,201.01 | 1,545.83 | 2.94% |
| NZX 50 Index | 13,397.00 | 15.44 | -0.12% |
| S&P 500 | 6,976.44 | 37.41 | 0.54% |
| S&P/ASX 200 | 8,870.10 | 3.80 | 0.04% |
| SSE Composite Index | 4,025.23 | 9.48 | 0.24% |